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ctivation of the Ras–MAPK signal transduction path-
way is necessary for biological responses both to
growth factors and ECM. Here, we provide evidence
that phosphorylation of S298 of MAPK kinase 1 (MEK1) by
p21-activated kinase (PAK) is a site of convergence for inte-
grin and growth factor signaling. We ﬁnd that adhesion to
ﬁbronectin induces PAK1-dependent phosphorylation of
MEK1 on S298 and that this phosphorylation is necessary for
efﬁcient activation of MEK1 and subsequent MAPK activation.
The rapid and efﬁcient activation of MEK and phosphorylation
A
 
on S298 induced by cell adhesion to ﬁbronectin is inﬂuenced
by FAK and Src signaling and is paralleled by localization
of phospho-S298 MEK1 and phospho-MAPK staining in
peripheral membrane–proximal adhesion structures. We
propose that FAK/Src-dependent, PAK1-mediated phos-
phorylation of MEK1 on S298 is central to the organization
and localization of active Raf–MEK1–MAPK signaling com-
plexes, and that formation of such complexes contributes
to the adhesion dependence of growth factor signaling to
MAPK.
 
Introduction
 
Serum growth factor stimulation of adherent fibroblasts acti-
vates MAPK through the sequential activation of Ras, Raf,
and MAPK kinase (MEK)* 1/2. Similarly, adhesion of cells
to ECM proteins in the absence of growth factors has been
reported to stimulate MAPK activity through a Ras-dependent
pathway (Schlaepfer et al., 1994; Moro et al., 1998; Wary et
al., 1998). Although Ras activation proceeds normally in
suspended cells treated with growth factors, MAPK activation is
uncoupled at the level of Raf or MEK (Lin et al., 1997;
Renshaw et al., 1997). These data are consistent with a model
in which adhesion and growth factor signals are integrated
downstream of Ras to regulate the functional interactions
between Ras and Raf or Raf and MEK. Thus, MEK appears
to be well positioned to serve as an anchorage sensor for
MAPK signaling.
Adhesion of cells to the ECM stimulates a number of sig-
naling pathways including FAK, Src, and those initiated by
the small GTPase Rac (Parsons et al., 2000). Integrin binding
to ECM proteins elicits the formation of focal complexes
and the recruitment and activation of two protein tyrosine
kinases, FAK and Src (Parsons et al., 2000). Integrin-induced
activation of FAK results in autophosphorylation of FAK on
tyrosine 397 (Y397), which correlates with increased catalytic
activity of FAK (Lipfert et al., 1992; Calalb et al., 1995) and
serves as a high affinity binding site for the SH2 domain of
Src family kinases.
The small GTPase Rac mediates lamellipodia extension
and focal complex formation initiated by integrin binding to
ECM proteins (Nobes and Hall, 1995). Activation of Rac
by cell adhesion stimulates membrane ruffling and the
formation of peripheral focal complexes through signaling cas-
cades involving the Rac–Cdc42 effector p21-activated kinase
(PAK; Bagrodia and Cerione, 1999). Localization of activated
PAK to focal adhesions and membrane ruffles influences cyto-
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skeletal dynamics through phosphorylation of LIM (Edwards
et al., 1999) and myosin light chain kinases (Sanders et al.,
1999). Signals initiated by Rac activation also influence the
Ras–MAPK pathway by synergizing with Raf to activate
MAPK (Frost et al., 1997), possibly by sensitizing MEK1 to
activation by Raf (Coles and Shaw, 2002). Recently, we dem-
onstrated that Rac–PAK signaling can enhance the association
of MEK1 and MAPK and that this pathway is required for
the formation of MEK1–MAPK complexes and MAPK acti-
vation upon cellular adhesion (Eblen et al., 2002). Moreover,
synergy between Rac and Raf promotes anchorage-indepen-
dent growth of fibroblasts (Qiu et al., 1995).
Because the Ras–MEK–MAPK signal transduction path-
way serves as a point of convergence for the regulation of
proliferation and migration by growth factors and ECM
proteins, we examined the adhesion-dependent activation of
both MEK and MAPK. Here, we provide evidence that
phosphorylation of MEK1 on S298 by PAK is one point at
which these two signaling pathways converge. We show that
adhesion to fibronectin (FN) induces PAK1 phosphoryla-
tion of MEK1 on S298 and that MEK1 S298 phosphor-
ylation is necessary for efficient activation-specific phos-
phorylation of MEK1 and subsequent MAPK activation.
Adhesion-dependent phosphorylation of MEK1 on S298 is
dependent in part upon FAK/Src signaling, consistent with
the localization of phospho-S298 MEK1 and phospho-
MAPK staining in peripheral membrane–proximal adhesion
structures. Moreover, synergistic activation of MEK1 by
growth factors and cell adhesion is diminished in cells ex-
pressing an MEK1 S298A mutant. We propose that FAK/
Src-dependent PAK phosphorylation of MEK1 on S298 is
central to the organization and localization of active Raf–
MEK1–MAPK signaling complexes and that formation of
such complexes underlies the observed adhesion dependence
of growth factor signaling to MAPK.
 
Results
 
Adhesion-dependent activation of MAPK
 
Cell adhesion to FN in the absence of growth factors acti-
vates both PAK1 and MAPK (Figs. 1 A and 8 B; Aplin et al.,
1999; Bagrodia and Cerione, 1999). Suspension of REF52
cells for 1 h in serum-free media greatly reduced phosphory-
lation of MAPK on the activating sites (i.e., T183/Y185 of
ERK2) (Fig. 1, A and B). Replating suspended cells on
FN stimulated both MEK activation site phosphorylation
(S218/S222) and MAPK phosphorylation within 10 min,
with maximal MEK phosphorylation on the activating sites
occurring between 5 and 10 min (Fig. 1, A and B). To deter-
mine the localization of this active pool of MAPK, REF52
cells suspended for 1 h in serum-free media were replated on
FN for 1 h in the absence of serum. Immunostaining with an
antibody to the phosphorylated form of MAPK revealed
phospho-MAPK colocalized with paxillin in well-defined
adhesions (Fig. 1 C, arrowhead). In addition, prominent
MAPK staining in peripheral structures resembling Rac-
induced focal complexes was observed. These structures were
distinguished from focal adhesions in that they did not con-
tain significant levels of paxillin staining (Fig. 1 C, arrow).
Cells spreading for shorter periods of time showed poorly or-
ganized phospho-MAPK staining (unpublished data).
The localization of phosphorylated MAPK in structures
resembling Rac-induced focal complexes prompted the ex-
amination of the role of Rac and its effector PAK in adhe-
sion-dependent MAPK regulation. As previously reported,
Rac signaling to PAK synergizes with Raf to regulate MAPK
activity (Frost et al., 1997). In addition, PAK has been re-
ported to phosphorylate MEK1 on S298 in vitro (Coles and
Shaw, 2002). To examine PAK phosphorylation of MEK1,
an antiphosphopeptide antiserum specific for phosphory-
lated S298 in MEK1 (p-S298 MEK1) was generated (see
Materials and methods). Recombinant group I PAK pro-
teins (PAK1, 2, and 3) stimulated phosphorylation of ki-
nase-defective MEK1 on a site specifically recognized by
anti–p-S298 MEK1 (Fig. 2 A, not depicted). Recognition of
phosphorylated MEK1 was abolished by preincubation of
anti–p-S298 MEK1 with the immunizing phosphopeptide,
but not with the corresponding nonphosphopeptide (un-
published data). In addition, anti–p-S298 MEK1 failed to
recognize MEK1 containing an alanine substitution at posi-
tion 298 (S298A; Fig. 2 B). Immunoblotting with anti–
p-S298 MEK1 revealed the loss of MEK1 S298 phosphor-
ylation in cells suspended in serum-free media (Fig. 3 A).
Replating on FN (Fig. 3 A), laminin, or vitronectin (not
Figure 1. Adhesion stimulates MAPK 
and MEK phosphorylation. REF52 cells 
were either continuously adherent 
(A) or suspended (S) and plated on FN 
for 5, 10, 20, or 40 min. Whole cell 
lysates were blotted with antiserum 
specific for (A) phosphorylated MAPK 
(p-MAPK; top) or ERK2 (bottom), or (B) 
MEK1 phosphorylated on S218/S222 
(p-S218/222MEK1; top) or MEK1 
(bottom). (C) REF52 cells were suspended 
for 1 h and plated on FN for 1 h before 
co-staining for p-MAPK (red) and paxillin 
(green). The arrows indicate focal 
complex-like structures containing 
p-MAPK; arrowheads indicate paxillin-
containing focal adhesions. Bar, 10  m.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
Adhesion-dependent MEK1 phosphorylation |
 
 Slack-Davis et al. 283
 
depicted) led to a rapid increase in MEK1 S298 phos-
phorylation (within 5 min), which was maintained through-
out the course of the assay and equivalent to levels observed
in continuously adherent cells. As shown in Fig. 3 B, anti–
p-S298 MEK1 selectively identified endogenous phosphory-
lated MEK1, but not MEK2, immunoprecipitated from
cells. Although MEK2 contains a site equivalent to S298, it
does not appear to be a substrate for phosphorylation by
PAK (Frost et al., 1997). Finally, adhesion-dependent MEK1
S298 phosphorylation was observed in many cell lines in-
cluding WI38, mouse embryo fibroblasts, CCL39, COS-1,
LNCaP, and MCF7 (unpublished data), indicating the gen-
erality of MEK1 S298 phosphorylation.
Because activated PAK is located in peripheral membrane
ruffles (Sells et al., 2000), we examined the localization of
p-S298 MEK1 in REF52 cells spreading on FN for 10 min.
Immunostaining revealed localization of p-S298 MEK1 in pe-
ripheral complexes coincident with paxillin staining (Fig. 3 C)
as well as in a poorly defined perinuclear compartment (not
depicted). After the cells spread for 60 min, paxillin staining
became more organized and localized to focal adhesions,
whereas anti–p-S298 MEK1 staining appeared diffused with
little detectable staining of paxillin-containing focal adhe-
sions. Together, these observations indicate that MEK1 S298
phosphorylation is induced early upon FN adhesion and
p-S298 MEK1 is localized in peripheral focal complexes.
 
PAK regulates adhesion-dependent phosphorylation of 
MEK1 on S298 and subsequent MEK1 activation
 
To examine whether PAK regulates adhesion-dependent
MEK1 S298 phosphorylation in vivo, COS-1 or REF52
cells expressing kinase-defective PAK1 (or vector control) to-
gether with HA-tagged wild-type MEK1 were placed in sus-
pension and replated on FN for the indicated times and
S298 phosphorylation was assessed by Western blotting. Ex-
pression of kinase-defective PAK1 significantly reduced FN-
stimulated S298 phosphorylation of exogenously expressed
MEK1 (Fig. 4 A, not depicted), indicating that PAK activa-
tion is necessary for adhesion-dependent MEK1 S298 phos-
phorylation. To determine if PAK activity is sufficient to
mediate MEK1 S298 phosphorylation in vivo, MEK1 S298
phosphorylation was examined in cells overexpressing acti-
vated PAK (T423E). REF52 cells expressing activated PAK
together with wild-type MEK1 exhibited elevated MEK1
S298 phosphorylation whether in suspension or plated on
FN (Fig. 4 B). Lastly, endogenous PAK1 immunoprecipi-
Figure 2. PAK directs MEK1 S298 phosphorylation in vitro. (A) In 
vitro kinase assays were performed using recombinant MEK1 and 
recombinant PAK3 as described in Materials and methods. (B) REF52 
cells were transfected with HA-tagged wild-type MEK1 or HA-MEK1 
S298A, suspended for 1 h and allowed to adhere to FN for 10 min. 
Anti-HA immunoprecipitates were analyzed and blotted with 
p-S298MEK1 (top) or MEK1 (bottom).
Figure 3. MEK1 S298 phosphorylation 
is regulated by cell adhesion. (A) REF52 
cells were treated as described in Fig. 1. 
Whole cell lysates were blotted with 
antiserum specific for phospho-S298 
MEK1 (p-S298MEK1; top) or MEK1 
(bottom). (B) REF52 cells were suspended 
(S) and replated on FN for 10, 20, or 40 
min. Anti-MEK1 or anti-MEK2 antiserum 
was used to immunoprecipitate 
endogenous proteins, which were 
subsequently blotted with anti–
p-S298MEK1 or anti-MEK1/2. (C) REF52 
cells were suspended and plated on FN 
for 10 min or 1 h before co-staining for 
p-S298MEK1 (red) and paxillin (green). 
The intense staining in the center of the 
cell represents perinuclear staining that 
was over-exposed to visualize peripheral 
structures. Bars, 10  m.T
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tated from REF52 cells was activated by adhesion to FN (see
Fig. 8 B), whereas endogenous PAK2 and 4 were not (not
depicted). Together, these data indicate that PAK1 activity
is both necessary and sufficient to stimulate MEK1 S298
phosphorylation and that PAK1-mediated phosphorylation
of MEK1 on S298 is regulated by cell adhesion.
MEK1 containing an S298A mutation was reported to
bind less efficiently to Raf than wild-type MEK1 indicating
that MEK1 S298 phosphorylation regulates the interaction
of MEK1 with its upstream activator (Frost et al., 1997). To
examine the requirement for S298 phosphorylation on FN-
stimulated MEK1 activation, cells expressing HA-tagged
MEK1 variants containing T292A, S298A, or T292A/
S298A mutations were placed in suspension or plated on FN
for 20 min. The MEK1 variants were immunoprecipitated
and blotted for p-S218/S222 MEK as an indicator of MEK
activation. Phosphorylation of S218/S222 was stimulated by
FN in cells expressing both wild-type MEK1 and MEK1
T292A, but not in cells expressing MEK1 S298A or MEK1
T292A/S298A (Fig. 5). Thus, MEK1 S298 is necessary for
efficient activation of MEK1 during adhesion.
 
FAK signaling regulates phosphorylation of MEK1
 
FAK and Src regulate a well-defined pathway that becomes
activated after integrin engagement (Parsons et al., 2000). In
addition, FAK/Src signaling has been shown to play a role in
FN-stimulated MAPK activation (Schlaepfer and Hunter,
1996; Schlaepfer et al., 1994). We examined the role of this
pathway in regulating MEK1 S298 phosphorylation using
FAK-deficient cells or PP2, an inhibitor of Src family ki-
nases. FAK-null fibroblasts or controls from wild-type litter-
mates were placed in suspension for 1 h and stimulated to
spread on FN for the indicated times (Fig. 6 A). Western
blot analysis of whole cell lysates using anti–p-S298 MEK1
demonstrated decreased levels (
 
 
 
70% wild-type levels deter-
mined by densitometry) and delayed time course of MEK1
S298 phosphorylation in FAK-null cells compared with
FAK-expressing wild-type fibroblasts (Fig. 6 A). Similarly,
decreasing FAK protein levels in REF52 cells using siRNAs
Figure 4. PAK regulates adhesion-dependent MEK1 S298 
phosphorylation. (A) COS-1 cells were transfected with myc-tagged 
kinase-defective PAK1 (Myc-PAK1-KR) or empty vector control 
together with HA-tagged MEK1. Cells were suspended (S) or plated 
on FN for 10, 20, or 30 min. Immunoprecipitates were formed using 
HA antiserum and blotted for p-S298MEK1 or MEK1. PAK1 expression 
was determined from whole cell lysates of transfected cells by 
immunoblotting with Myc antiserum. (B) REF52 cells were transiently 
cotransfected with HA-MEK1 together with myc-PAK1 T423E or the 
appropriate empty vector. Cells were suspended for 90 min (S) and 
allowed to adhere to FN-coated dishes for 20 min (FN). Anti-HA 
immunoprecipitates were formed and blotted with HA antiserum 
(middle), and subsequently with anti-pS298MEK1 (top). Western 
blotting of lysates with anti-myc antiserum confirmed expression 
of activated PAK1 (bottom).
Figure 5. Phosphorylation of MEK1 on S298 regulates MEK1 
activation. REF52 cells were transiently transfected with HA-MEK1, 
HA-MEK1 T292A, HA-MEK1 S298A, or HA-MEK1 T292A/S298A. 
Cells were suspended for 90 min (S) and plated on FN for 20 min 
(FN). Anti-HA immunoprecipitates were formed and blotted with 
anti-p-S218/S222MEK1 (top), anti-pS298MEK1 (middle), or anti-HA 
antiserum (bottom).
Figure 6. FAK signaling regulates MEK1 S298 phosphorylation. 
(A) FAK-null fibroblasts or cells from wild-type littermate controls 
were suspended (S), plated on FN for 5, 15, or 45 min, or remained 
adherent (A). Whole cell lysates were blotted with p-S298MEK1, 
MEK1, p-MAPK, or ERK2 antisera. (B) FAK-null fibroblasts transfected 
with myc-tagged wild-type FAK, FAK Y397F, or empty vector control 
together with HA-tagged wild-type MEK1 were suspended (S) and 
replated on FN for 5, 10, or 20 min. Immunoprecipitates were formed 
using HA antiserum and blotted for p-S298MEK1 or MEK1. FAK 
expression was determined from whole cell lysates of transfected cells 
using Myc antiserum. FAK autophosphorylation was determined by 
immunoblotting with Y397 FAK phospho-specific antibodies.T
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also resulted in decreased and delayed MEK1 S298 phos-
phorylation upon adhesion of these cells to FN (unpub-
lished observations; Fig. S1). In both FAK-null and -express-
ing cells, MAPK phosphorylation paralleled MEK1 S298
phosphorylation (Fig. 6 A).
The role of FAK in MEK1 phosphorylation was assessed
by reconstituting FAK-null cells with wild-type FAK or the
FAK autophosphorylation mutant Y397F. Phosphorylation
of cotransfected MEK1 on S298 was measured in suspended
cells or cells allowed to adhere to FN for the indicated times.
Expression of wild-type FAK, but not the FAK autophos-
phorylation mutant, Y397F, restored MEK1 S298 phos-
phorylation in FN-stimulated cells when compared with the
empty vector control (Fig. 6 B). Transient overexpression of
wild-type FAK under these conditions resulted in adhesion-
independent FAK activation, as indicated by constitutive
FAK Y397 phosphorylation in suspended cells (Fig. 6 B).
Concomitantly, overexpression of wild-type FAK also stim-
ulated MEK1 S298 phosphorylation in suspended cells (Fig.
6 B), which paralleled the increased phosphorylation of
S298 observed in suspended cells overexpressing activated
PAK1 (Fig. 4 B). The FAK-directed increase in MEK1 S298
phosphorylation was inhibited by coexpression of kinase-
defective PAK1, whereas activated PAK1 stimulated MEK1
S298 phosphorylation in cells expressing Y397F FAK (un-
published data). Together, these observations indicate a di-
rect role for FAK activity in stimulating PAK1-directed
MEK1 S298 phosphorylation.
Adhesion-mediated activation of FAK results in the stim-
ulation of Src after binding to FAK phosphorylated on Y397
(Cobb et al., 1994; Schaller et al., 1994, 1999; Reiske et al.,
1999). Because Y397F FAK was unable to restore MEK1
S298 phosphorylation, we assessed the role of Src in regulat-
ing adhesion-dependent MEK1 S298 phosphorylation using
the Src family kinase inhibitor, PP2. REF52 cells were sus-
pended in serum-free media in the presence or absence of
PP2, and replated on FN in the continued presence or ab-
sence of PP2 (Fig. 7 A). PP2 treatment decreased the extent
and delayed the time course of S298 phosphorylation after
FN stimulation (Fig. 7 A), similar to the observations for
FAK-null cells (Fig. 6 A). MEK1 S298 phosphorylation in
cells stimulated to adhere to FN for 5 min in the presence of
PP2 was 
 
 
 
28% the level of untreated cells when normalized
to MEK1 loading control. Overexpression of activated PAK
(PAK1 T423E) rescued the decrease in MEK1 S298 phos-
phorylation induced by PP2 treatment (Fig. 7 B). In addi-
tion, active PAK-stimulated MEK1 S218/S222 phosphory-
lation on wild-type MEK1 and to a lesser degree on MEK1
S298A. Finally, cells deficient for Src, Yes, and Fyn also
showed decreased and delayed MEK1 S298 phosphorylation
upon plating on FN (Fig. S2). These results indicate that Src
or a Src family kinase is involved in regulating the path-
way(s) leading to MEK1 S298 phosphorylation.
In addition to regulating MEK1 S298 phosphorylation,
PP2 treatment virtually eliminated MEK activation mea-
sured by S218/S222 phosphorylation and significantly de-
creased MAPK phosphorylation in response to FN stimula-
tion (Fig. 7 A). At least two mechanisms exist by which
MEK1 activation could be blocked by the Src inhibitor. Be-
cause S298 phosphorylation is necessary for MEK1 activa-
tion upon adhesion and is blocked by PP2, Src might regu-
late activation through its effects on S298 phosphorylation.
Alternatively, because Src is reported to phosphorylate and
activate Raf (Fabian et al., 1993; Marais et al., 1995), PP2
might function to decrease Raf activation upon adhesion in
addition to regulating S298 phosphorylation. To distinguish
between these possibilities, we examined the effect of inhib-
iting Src on Raf and PAK activity. REF52 cells were sus-
pended for 1 h in the presence or absence of PP2 and stimu-
lated with FN for 10 min in the continued presence or
absence of PP2. C-Raf was immunoprecipitated and kinase
activity was assessed in vitro by measuring 
 
32
 
P incorporation
into recombinant kinase–defective MEK1. In the absence of
PP2, FN induced little change in c-Raf activity (Fig. 8 A).
On the other hand, PP2 treatment resulted in increased
c-Raf activity in cells adhering to FN (Fig. 8 A). Despite the
observed increase in c-Raf activity after PP2 treatment,
phosphorylation of endogenous MEK1 on the activating
sites was not observed (Fig. 7 A; not depicted).
The simplest interpretation of these observations is that
the block in MEK1 activation in response to PP2 treatment
results from inhibiting PAK1-mediated phosphorylation of
Figure 7. Src inhibition alters PAK-mediated MEK phosphorylation. 
(A) REF52 cells were incubated in suspension with 50  M PP2 or 
DMSO control (S) and plated on 10  g/ml FN for 5, 10, 20, or 40 min 
in the continued presence or absence of PP2. Whole cell lysates were 
blotted with p-S298MEK1, p-S218/S222MEK1, MEK1, p-MAPK, or 
ERK2 antisera. Densitometric analysis demonstrated that the intensity 
of p-S298MEK1 after a 5-min plating on FN in the presence of 50  M 
PP2 was  28% the level of the DMSO-treated control when 
normalized to an MEK1 loading control. The observed decrease in 
p-MAPK levels in lane 9 was not reproducible. (B) REF52 cells were 
cotransfected with HA-tagged MEK1 constructs and PAK1 T423E or 
vector control, incubated in suspension with 50  M PP2 or DMSO 
control (S) and plated on FN for 20 min. Anti-HA immunoprecipitates 
were formed and blotted with pS218/S222 antiserum (top), HA 
antiserum (second [from top] panel), and subsequently with anti-
pS298MEK1 (third [from top] panel). Western blotting of lysates with 
anti-myc antiserum confirmed expression of activated PAK1 (bottom).T
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MEK1 on S298. Therefore, we examined the effect of PP2
treatment on PAK1 activity in response to FN stimulation.
Endogenous PAK1 was immunoprecipitated from REF52
cells suspended in the presence or absence of PP2 or replated
on FN in the continued presence or absence of PP2. Activ-
ity was assessed by measuring the ability of immunoprecipi-
tated PAK1 to phosphorylate recombinant kinase–defective
MEK1 on S298 in vitro (Fig. 8 B). FN stimulated immune
complex PAK1 activity within 5 min of replating, whereas
PP2 treatment delayed the activation of PAK1 from 5 to 20
min (Fig. 8 B). Thus, the effects of PP2 on activation of
PAK by FN parallel the effects of PP2 on endogenous
MEK1 S298 phosphorylation. Together, these observations
indicate that FAK and Src signal transduction cascades con-
tribute to the FN-stimulated MEK1 and MAPK activation
primarily by stimulating PAK-mediated phosphorylation of
MEK1 on S298.
Because Src-dependent MEK1 S298 phosphorylation is
required for adhesion-mediated activation of MEK (Fig. 5)
and subsequent MAPK activation (Eblen et al., 2002), we
examined the effect of Src inhibition on phospho-MAPK lo-
calization in REF52 cells. Cells were suspended for 1 h and
allowed to spread on FN for 1 h in the continued presence
or absence of PP2 and immunostained for phospho-MAPK
(red) and paxillin (green). Consistent with a previous report
(Fincham et al., 2000), inhibition of Src activity had no ef-
fect on the localization of phospho-MAPK to focal adhe-
sions (Fig. 9, arrowheads). However, PP2 decreased the ex-
tent of phospho-MAPK staining in peripheral structures
reminiscent of Rac-induced adhesion complexes. Indeed,
only 22% of the cells treated with PP2 exhibited peripheral
adhesion complexes containing phospho-MAPK, whereas
almost all (98%) of the untreated REF52 cells displayed pe-
ripheral adhesion complexes rich in phospho-MAPK stain-
ing (Fig. 9, arrows). These observations indicate that, in ad-
dition to decreasing MAPK activation, inhibition of Src
activity reduces the pool of activated MAPK recruited to
newly formed adhesion complexes.
 
MEK1 S298 phosphorylation modulates growth
factor–stimulated MEK1 activation
 
ECM adhesion has been reported to influence serum growth
factor–stimulated MAPK activation at the level of Raf or
MEK (Lin et al., 1997; Renshaw et al., 1997). Indeed,
REF52 cells suspended for 90 min and stimulated with
growth factors or replated on FN for 30 min resulted in a
modest induction of MAPK phosphorylation (Fig. 10 A).
Stimulating fibroblasts with growth factors while they ad-
here to FN for 30 min resulted in an enhanced activation of
MAPK phosphorylation (Fig. 10, A and B) as reported pre-
viously (Roovers et al., 1999). The ability of FN to amplify
growth factor–stimulated MAPK activity was most evident
at lower, more physiologically relevant concentrations of
EGF (0.125 ng/ml; Fig. 10 B, lanes 9 and 10), whereas
Figure 8. Adhesion-dependent c-Raf and PAK 
activity are affected by inhibiting Src. (A) c-Raf 
activity was determined from REF52 cells incubated 
in suspension with 50  M PP2 or DMSO solvent 
control (S) and plated on FN for 5 or 10 min. 
Immunoprecipitates were formed using either c-Raf 
antiserum, or matched control antiserum raised 
against the GAL4 transactivation domain, and kinase 
assays were performed with kinase-defective GST-
MEK1 as described in Materials and methods (top). A reaction blank (lane B) confirms the absence of MEK kinase activity in the substrate and 
c-Raf antiserum, and a reaction lacking GST-MEK1 (lane 8) confirms that MEK1 is the phosphorylated substrate in these assays. Loading controls 
(bottom) demonstrate similar levels of c-Raf protein in the appropriate assays. (B) PAK1 activity was determined as described above for c-Raf 
activity (A) except cells were also plated for 5, 10, or 20 min and immunoprecipitates were formed using PAK1 antiserum. PAK1 activity was 
assessed by blotting the recombinant MEK1 substrate with the p-S298 antiserum (top). The PAK1 loading control is shown in the bottom panel. 
Lane B denotes a reaction blank in which PAK1 antibody was incubated with lysis buffer instead of lysate before the kinase assay.
Figure 9. Src inhibition alters the 
location of phospho-MAPK. REF52 cells 
were suspended in the presence or 
absence of 50  M PP2 and plated on FN 
for 1 h in the continued presence or 
absence of PP2 before co-staining for 
p-MAPK (red) and paxillin (green). The 
arrows indicate peripheral adhesion 
complexes containing p-MAPK; arrow-
heads indicate paxillin-containing focal 
adhesions. Bar, 10  m.T
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higher concentrations of EGF (10 ng/ml) overcame the ad-
hesion requirement to efficiently activate MAPK (Fig. 10 B,
lanes 1 and 2). In addition, MEK1 activation was maximally
activated by stimulation with both growth factors and adhe-
sion to FN (Fig. 10 C). To determine whether MEK1 S298
phosphorylation plays a role in MEK1 activation in response
to growth factor stimulation, HA-tagged wild-type MEK1
or MEK1 S298A was immunoprecipitated from REF52 cells
that were serum-starved, suspended, and either stimulated
with EGF in suspension, replated onto FN, or stimulated
and replated. In the absence of adhesion, growth factor stim-
ulation of REF52 cells resulted in equivalent S218/S222
phosphorylation of exogenously expressed wild-type MEK1
or MEK1 S298A (Fig. 10 D, lanes 2 and 8). However,
growth factor stimulation of adherent cells expressing
MEK1 S298A resulted in 
 
 
 
50% less activation of MEK
S218/S222 compared with cells expressing wild-type MEK1
(Fig. 10 D, lanes 4–6 and 10–12). Together, these results in-
dicate that adhesion-dependent MEK1 S298 phosphoryla-
tion regulates, at least in part, the maximal activation of
MEK1 by serum growth factors.
 
Discussion
 
This paper provides evidence that phosphorylation of MEK1
on S298 is a convergence point for integrating growth factor
signaling and adhesion signaling via the MAPK pathway.
PAK1 efficiently phosphorylated MEK1 on S298 in vitro
and in vivo. MEK1 S298 phosphorylation was necessary for
efficient activation of MEK1 and subsequent MAPK activa-
tion. The rapid phosphorylation of MEK on S298, and its
efficient activation in response to adhesion to FN required
FAK and Src and were paralleled by localization of phospho-
S298 MEK1 and phospho-MAPK staining in peripheral
membrane–proximal adhesion structures. Thus, these exper-
iments identify MEK1 as a target of combinatorial signaling
through growth factor and integrin receptors.
The adhesion-dependent PAK1 phosphorylation of MEK1
on S298 indicates that MEK1, through its functional cou-
pling of Raf and MAPK, might serve as a sensor for the adhe-
sive status of cells or cellular compartments (e.g., protrusions
at the leading edge). In addition, our work provides a molecu-
lar framework for the observation that stimulation of cells in
suspension with physiologic concentrations of growth factor
fails to activate MEK and MAPK despite activating Ras and
Raf. These observations suggest that anchorage-independent
activation of PAK and consequent phosphorylation of MEK1
might contribute to increased migration and anchorage-inde-
pendent proliferation during malignancy.
 
Role of Rac, PAK, and S298 phosphorylation 
in MAPK activation
 
Previous studies have shown that Rac signaling to PAK syn-
ergizes with Raf to regulate MAPK activity (Frost et al.,
1997). The PAK effects on MAPK signal transduction ap-
pear to be mediated by phosphorylation of Raf on S338
(King et al., 1998; Chaudhary et al., 2000). PAK-mediated
phosphorylation of c-Raf has been reported to stimulate its
Figure 10. Adhesion-dependent MEK1 S298 
phosphorylation promotes maximal MEK1 
activation in response to growth factor stimulation. 
(A) REF52 cells were suspended for 90 min and 
either stimulated for 30 min with EGF and IGF-1 in 
suspension, replated on FN for 30 min, or stimulated 
with EGF and IGF-1 while they attached to FN for 
30 min. Whole cell lysates were blotted with 
p-MAPK or ERK2 antisera. (B) REF52 cells were 
placed in suspension for 90 min and either 
stimulated in suspension for 30 min with the 
indicated concentrations of EGF or replated on FN 
in the presence of the indicated concentrations of 
EGF for 30 min. Whole cell lysates were blotted 
with p-MAPK or ERK2 antisera. (C) Cells were 
treated as in A, and whole cell lysates were blotted 
with p-S218/222 MEK or MEK1 antisera. (D) REF52 
cells were transiently transfected with HA-MEK1 
(lanes 1–6) or HA-MEK1 S298A (lanes 7–12). Cells 
were suspended in serum-free media for 90 min 
and either kept unstimulated in suspension (lanes 1 
and 7), stimulated in suspension with EGF for 20 
min (lanes 2 and 8), allowed to adhere to FN (lanes 
3 and 9) or allowed to attach to FN while stimulated 
with EGF for the indicated times (lanes 4–6 and 
10–12). Anti-HA immunoprecipitates were formed 
and blotted with p-S218/222 MEK1, p-S298MEK1 
or HA antisera. Densitometry and normalization 
to the loading controls revealed that S218/222 
phosphorylation of MEK1 S298A was  50% that 
seen in the wild-type protein.T
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activity (King et al., 1998). Furthermore, adhesion of
COS7 cells overexpressing c-Raf mutants has been reported
to stimulate c-Raf S338 phosphorylation through a phos-
phoinositide 3-kinase (PI3K)–dependent mechanism (Chaud-
hary et al., 2000). We did not observe stimulation of en-
dogenous c-Raf S338 phosphorylation (not depicted) or
endogenous c-Raf activity (Fig. 8 A) when cells were re-
plated on FN. Moreover, inhibiting PI3K activity with
LY294002 had no effect on MEK1 S298 phosphorylation
(unpublished data). These discrepancies could reflect differ-
ences in the pathways used by different cell types or an alter-
ation in pathway usage when proteins are overexpressed.
Indeed, overexpression of active PAK1 led to a modest stim-
ulation of the activation of MEK1 S298A as judged by in-
creased phosphorylation of S218/S222. This observation
suggests the possibility that overexpression of activated
PAK1 may obviate normal signaling constraints by phos-
phorylating Raf on S338, thus enhancing MEK activation in
a S298-independent manner. This is consistent with obser-
vations showing adhesion-dependent Raf activation after
PAK phosphorylation of Raf-S338 in COS7 cells overex-
pressing c-Raf mutants (Chaudhary et al., 2000). Based on
these observations, we suggest that the Raf–MEK–MAPK
pathway may be exquisitely sensitive to the level of PAK1 ac-
tivation and in the case of adhesion of REF52 cells to FN,
PAK1 is primarily a modulator of MEK1 activation.
An alternative possibility to explain PAK-Raf synergy is
that PAK-dependent phosphorylation of MEK1 on S298
leads to enhancement of MAPK by modulating both the
physical and functional interactions between Raf, MEK, and
MAPK. Frost and co-workers showed that MEK1 with mu-
tations of T292 and S298 to alanine bound c-Raf less effi-
ciently than did wild-type MEK1 (Frost et al., 1997). In-
deed, recent evidence has shown that PAK phosphorylation
of S298 sensitizes MEK1 to activation by Raf (Coles and
Shaw, 2002). Here, we show that MEK1 S298 phosphoryla-
tion is dependent on cell adhesion (Fig. 3 A) and that adhe-
sion-dependent phosphorylation of MEK1 on S298 was re-
quired for phosphorylation and activation of MEK1 in
response to FN stimulation (Fig. 5). However, MEK1 acti-
vation occurred in the absence of a measurable increase in
c-Raf activity. One possible explanation is that adhesion-
dependent activation of MEK1 is regulated by phosphoryla-
tion from MEK kinases other than Raf, including MEK ki-
nase (MEKK) 1, 2, and 3, which have been implicated in
stimulating the MAPK pathway (Ellinger-Ziegelbauer et al.,
1997; Xia et al., 1998). We cannot rule out the possibility
that other MEK kinases are activated by adhesion to FN,
however, PAK1 phosphorylation of MEK1 would be re-
quired for MEKK to activate MEK1 because MEK1 S298A
was not phosphorylated on the activating sites upon plating
on FN (Fig. 5). An alternative possibility is that adhesion-
dependent PAK1 activation and subsequent phosphoryla-
tion of MEK1 on S298 is sufficient to stimulate MEK1
phosphorylation and activation by low levels of c-Raf activ-
ity merely by enhancing the interaction between c-Raf and
MEK1. In both scenarios, adhesion-dependent PAK1 phos-
phorylation sensitizes MEK1 for activation from the up-
stream activator. Previous observations demonstrated that
MEK1 was constitutively phosphorylated on S298 in the
presence or absence of serum (Catling et al., 1995), signify-
ing that MEK1 S298 phosphorylation is regulated uniquely
by cell adhesion. Furthermore, in a separate study we show
that adhesion-dependent phosphorylation of MEK1 on
S298 is necessary for the formation of MEK1–MAPK com-
plexes and subsequent MAPK activation (Eblen et al.,
2002). Therefore, we suggest a unique activation mecha-
nism by which cell adhesion stimulates MAPK activity by
sensitizing MEK1 to activation by basal levels of c-Raf activ-
ity or a different MEKK and by promoting the assembly of
MEK1–MAPK signaling complexes.
In addition to regulating the amplitude of MAPK activity,
PAK1 likely influences the spatial regulation of MAPK by
stimulating localized assembly of MEK1-signaling com-
plexes in focal adhesions and peripheral focal complexes. Ac-
tivated PAK1 localizes to focal adhesions and membrane ruf-
fles (Sells et al., 2000). Indeed, PAK1 activity, reflected by
phospho-S298 MEK1 staining, was observed in peripheral
membrane structures 10 min after replating onto FN (Fig. 3
C). We propose that MEK1 phosphorylated on S298 stimu-
lates MAPK activity in peripheral membrane structures by
promoting activation complexes containing Raf and MAPK.
MAPK, once activated, might down-regulate components of
its activation pathway (Brunet et al., 1994; Dong et al.,
1996), which could result in the dissociation of MEK from
MAPK, allowing MEK to translocate to additional cellular
compartments as was observed at later time points after re-
plating (Fig. 3 C, 60 min FN).
 
FAK and Src as regulators of MAPK
 
FAK and Src positively regulate phosphorylation of MEK1
on S298 by PAK1. Cells deficient in FAK expression dis-
played decreased MEK1 S298 phosphorylation and a de-
layed time course of phosphorylation after FN stimulation
(Fig. 6 A), which could be rescued by activated PAK (not
depicted). The observation that wild-type FAK, but not
FAK Y397F, which is incapable of interacting with Src,
stimulated MEK1 S298 phosphorylation in FAK-deficient
cells strongly indicates that these kinases function coordi-
nately to regulate downstream signals to Rac and PAK. This
is supported by similar observations in Src/Yes/Fyn-deficient
cells and the observation that PP2 was an effective inhibi-
tor of MEK1 298 phosphorylation. No change in MEK1
S298 phosphorylation was observed in cells treated with
LY294002 (unpublished data), suggesting that PI3K, which
also binds FAK phosphorylated on Y397 (Reiske et al.,
1999), is not required for MEK1 S298 phosphorylation.
Inhibition of Src family kinases with PP2 not only inhib-
ited MEK1 S298 phosphorylation, but also decreased phos-
phorylation of both MEK and MAPK on their respective ac-
tivating sites in response to adhesion. Furthermore, PP2
inhibited the appearance of activated MAPK at the cell pe-
riphery. PP2 might inhibit Raf-mediated activation of
MEK1 by reducing MEK1 S298 phosphorylation, or alter-
natively might reduce Raf activity directly, because Src phos-
phorylation of Raf has been shown to increase its activity
(Fabian et al., 1993; Marais et al., 1995). However, adhe-
sion to FN failed to stimulate Raf activity. Interestingly, RafT
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activity was actually increased after PP2 treatment even
though phosphorylation of its downstream substrate MEK1
was suppressed. In contrast, adhesion-dependent PAK1 acti-
vation was decreased by PP2 treatment consistent with the
hypothesis that FN-stimulated MEK1 activation is regulated
primarily by PAK1 phosphorylation of MEK1 on S298.
These observations, together with data showing that phos-
pho-MAPK staining was decreased in peripheral focal com-
plexes after PP2 treatment, indicate that the activation and
localization of active MAPK to Rac-like focal complexes is
regulated by Src-mediated activation of PAK1 and subse-
quent phosphorylation of MEK1.
 
Integrin activation of PAK
 
Integrin engagement leads to PAK activation and the target-
ing of PAK to adhesion complexes (Manser et al., 1998; del
Pozo et al., 2000; West et al., 2001). The small GTPases
Rac and Cdc42 are potent activators of PAK and are acti-
vated in response to integrin ligation. The molecular path-
ways leading to Rac–Cdc42 and PAK activation are likely
numerous, however, the data presented in this paper indi-
cate that in the setting of cell adhesion to FN, FAK, and Src
play a significant (but not exclusive) role in the activation of
PAK1. Previous studies have implicated PI3K in the in-
tegrin-dependent activation of PAK1, Raf, and MAPK
(Chaudhary et al., 2000). In our work, the PI3K inhibitor
LY294002 had little effect on the adhesion-induced phos-
phorylation of MEK1 on S298, consistent with activation
via the integrin FAK/Src-directed pathway. Of interest is the
recent observation that DOCK180, when combined with its
binding partner ELMO, is an efficient activator of Rac
(Brugnera et al., 2002). This suggests the possibility that
FAK/Src-dependent activation of p130 Crk–associated sub-
strate and Crk may lead to the activation of DOCK180/
ELMO and the subsequent activation of Rac and PAK.
 
Biological importance of adhesion signaling to MEK
 
Active MAPK and pS298 MEK1 were found proximal to
immature focal complexes and focal adhesions after FN
stimulation. As pS298 MEK1 is a surrogate for active PAK,
these findings support a role for these kinases in the regula-
tion of focal adhesion dynamics and cell migration. MAPK
and PAK activities have both been found to be important for
cell migration (Klemke et al., 1997; Kiosses et al., 1999;
Sells et al., 1999). Moreover, Rac overexpression enhances
MAPK-dependent migration of cells stimulated with low
levels of EGF while having little effect on migration in re-
sponse to high concentrations of growth factor (Leng et al.,
1999). PAK phosphorylation of MEK1 on S298, which is
required for MEK1 activation-specific phosphorylation in
the absence of inducible Raf activity, provides a mechanism
whereby suboptimal Raf activation likely achieved with shal-
low gradients of growth factor stimulation could promote
maximal MAPK activity in a localized manner.
In addition to stimulating MAPK activity, cell adhesion
also regulates growth factor–induced activation of MAPK
(Renshaw et al., 1997). Without an appropriate ECM, se-
rum growth factors stimulate Ras activity, however, cell ad-
hesion is required to activate MAPK at the level of Raf or
MEK (Lin et al., 1997; Renshaw et al., 1997). Furthermore,
the adhesion requirement for growth factor–induced MAPK
activation is lost in cells overexpressing activated FAK (Ren-
shaw et al., 1999) or PAK (Howe and Juliano, 2000). Our
findings that adhesion-dependent PAK1 activation is re-
quired for MEK1 activation by Raf and for MEK1–MAPK
coupling (Eblen et al., 2002) provide a mechanism to ac-
count for the disconnect between Raf and MEK in serum-
stimulated suspended cells. In the absence of cell adhesion
and MEK1 S298 phosphorylation, growth factor–stimulated
Raf activity resulted in reduced phosphorylation and activa-
tion of MEK, thereby rendering MAPK activation depen-
dent on cell adhesion to ECM. Because sustained MAPK ac-
tivity regulates adhesion-dependent growth (Assoian and
Schwartz, 2001), anchorage-independent growth may result
from continuous PAK phosphorylation of MEK1 on S298.
Indeed, PAK has been implicated in regulating anchorage-
independent growth (Tang et al., 1997, 1999; Vadlamudi et
al., 2000). Furthermore, we find adhesion-independent
MEK1 S298 phosphorylation in highly tumorigenic human
prostate cell lines (unpublished observations). Therefore, the
loss of adhesion-dependent regulation of PAK activity would
have a profound impact on tumorigenesis and metastatic
progression by affecting cellular proliferation and migration.
 
Materials and methods
 
Reagents
 
REF52 and COS-1 (American Type Culture Collection) cells were grown in
DME supplemented with 10% FBS (Life Technologies). FAK-null fibro-
blasts, provided by D. Ilic (Ilic et al., 1995) were grown in DME supple-
mented with 10% FBS (Life Technologies), 1% sodium pyruvate, 1% non-
essential aa, and 0.5 
 
 
 
M 
 
 
 
-mercaptoethanol (Bio-Rad Laboratories). PP2
(Calbiochem) and Src family kinase inhibitor were reconstituted in DMSO
and used at a final concentration of 50 
 
 
 
M. The following antibodies were
used: phospho-MAPK (New England Biolabs, Inc.; Zecevic et al., 1998);
MEK1/2 (New England Biolabs, Inc.); phospho-MEK1 S218/S222 (Sigma-
Aldrich); ERK2 (clone B3B9; Upstate Biotechnology); MEK1, MEK2, and
paxillin (Transduction Labs); HA (clone 12CA5); myc (clone 9E10; Trans-
duction Labs); p-FAK Y397 (Biosource International); PAK (anti-N20 for
immunoprecipitation; anti-C19 for Western analysis); c-Raf (anti–C-12);
and Gal4 transactivation domain (Santa Cruz Biotechnology, Inc.).
 
Generation and characterization of phospho-specific 
MEK1 antibody
 
The anti-MEK (pS298) antibody was prepared by Research Genetics. Rab-
bits were immunized with the KLH-conjugated phosphopeptide, R-T-P-G-
R-P-L-pS-S-Y-G-M-D-S. Antibodies from pooled bleeds were affinity puri-
fied over a phosphopeptide column and passed over a nonphosphorylated
peptide column to remove antibodies specific for the nonphosphorylated
peptide. The purified antibody was tested for specificity both in ELISA as-
says, using bound phosphopeptide versus nonphosphopeptide, and on im-
munoblots of purified GST-MEK. Recombinant MEK1 was purified as de-
scribed previously (Catling et al., 2001). Recombinant His-tagged PAK3
was a gift from S. Bagrodia and R.A. Cerione (Cornell University, Ithaca,
NY). Purified MEK1 was incubated with or without recombinant PAK3 in
0.5 mM 
 
 
 
-[
 
32
 
P]ATP (
 
 
 
8,400 cpm/pmol), 10 mM MgCl
 
2
 
, 1 mM DTT, and
25 mM Hepes-NaOH, pH 7.4, for 20 min at 30
 
 
 
C. Reactions were termi-
nated with SDS-PAGE sample buffer and resolved on 10% gels. Incorpora-
tion was analyzed by autoradiography and immunoblotting. Control reac-
tions lacking MEK1 showed no incorporation or p-S298 MEK1 reactivity,
and Cerenkov counting indicated that PAK3 rapidly phosphorylates MEK1
to stoichiometry under these conditions.
 
Plasmids and transfection assays
 
All constructs in this work used a cytomegalovirus promoter to drive ex-
pression of peptide epitope–tagged protein. Wild-type MEK1, MEK1T
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T292A, MEK1 S298A, MEK1 T292A/S298A, and kinase-defective MEK1
(K97A) subcloned into pCMVHA (Catling et al., 1995), wild-type FAK, and
the autophosphorylation mutant (Y397F) of FAK subcloned into pCMV-
myc (Xiong and Parsons, 1997), and myc-tagged PAK1-K299R and PAK
T423E subcloned into pRK5-myc (Weed et al., 1998).
To test the phosphorylation of MEK1 mutants (T292A, S298A, or T292A/
S298A), two 150-mm dishes containing 2 
 
 
 
 10
 
6
 
 REF52 were each trans-
fected with 0.25 
 
 
 
g each MEK1 construct and 12.25 
 
 
 
g pCMVHA using
Superfect. The effect of kinase-defective PAK on MEK1 S298 phosphoryla-
tion was tested by transfecting two 150-mm dishes containing 1.5 
 
 
 
 10
 
6
 
COS-1 cells each with 3 
 
 
 
g PAK1 K299R or empty vector together with
1.25 
 
 
 
g wild-type MEK1 using Lipofectamine. The effect of activated PAK
on MEK1 phosphorylation was tested by transfecting two 150-mm dishes
containing 1.5 
 
 
 
 10
 
6
 
 REF52 cells each with 4 
 
 
 
g PAK1 T423E or empty
vector together with 1 
 
 
 
g wild-type MEK1 using Superfect (QIAGEN). To
assess the role of wild-type FAK or FAK Y397F on MEK1 phosphorylation,
4 
 
 
 
 10
 
6
 
 FAK-deficient cells were plated on each of two 150-mm plates per
construct and transfected each with 10.75 
 
 
 
g FAK, FAK Y397F, or empty
vector together with 1.25 
 
 
 
g wild-type MEK1 using Polyfect (QIAGEN) ac-
cording to the manufacturer’s instructions. 24 h later, the cells were har-
vested, pooled from two dishes, suspended for 60–90 min in serum-free
media, and replated on dishes coated with 10 
 
 
 
g/ml FN (Sigma-Aldrich)
for 5–30 min. To test the effects of growth factors and cell adhesion on
MEK and MAPK activation, REF52 cells were serum-starved for 16 h in
DME containing 0.2% FBS, suspended in serum-free DME for 90 min, and
either kept in suspension, stimulated in suspension with the indicated con-
centrations of EGF or with 2 ng/ml EGF and 100 ng/ml IGF-1, or allowed
to adhere to 10 
 
 
 
g/ml FN in the presence or absence of growth factors for
30 min. The role of MEK1 S298 phosphorylation in MEK1 activation was
determined by transfecting REF52 cells with HA-tagged wild-type MEK1 or
HA-tagged MEK1 S298A. After 32 h, the cells were serum-starved in DME
containing 0.2% FBS for 16 h. Cells were suspended in serum-free DME
for 90 min and either treated with 3 ng/ml EGF in suspension, allowed to
adhere to 10 
 
 
 
g/ml FN, or allowed to adhere to FN in the presence of EGF
for the indicated times. For all transfection experiments, MEK1 phosphory-
lation was determined after immunoprecipitation using HA antibodies as
described in the next section.
 
Immunoprecipitation and Western analysis
 
Suspended cells or those that were allowed to reattach to 10 
 
 
 
g/ml FN
were lysed in supplemented RIPA buffer (50 mM Hepes, 0.15 M NaCl, 2
mM EDTA, 0.1% Nonidet P-40, and 0.05% sodium deoxycholate, pH 7.2)
containing 1 mM PMSF, 100 mM leupeptin, and 0.05 TIU/ml aprotinin (1
mM Na
 
3
 
VO
 
4
 
, 40 mM NaF, and 10 mM Na
 
4
 
P
 
2
 
O
 
7
 
). Attached cells were
lysed directly on the plate in supplemented RIPA buffer. Lysates were incu-
bated for 1 h at 4
 
 
 
C with protein A–Sepharose beads (Amersham Bio-
sciences) preconjugated with specific IgG. The immunoprecipitated pro-
teins were resolved on 10% SDS-PAGE gels, transferred to nitrocellulose,
and blotted with p-S218/S222 MEK1, 12CA5 (mAb to the HA tag), MEK1,
or MEK2 followed by HRP-conjugated secondary antibody. The immuno-
blots were stripped (100 mM 
 
 
 
-mercaptoethanol, 2% SDS, and 62.5 mM
Tris-HCl, pH 6.7) and blotted with p-S298 MEK1 followed by incubation
with HRP-conjugated goat anti–rabbit secondary antibodies and visualiza-
tion by ECL (Amersham Biosciences). Western analysis of whole cell ly-
sates was performed using 25–50 
 
 
 
g protein.
 
Kinase assays
 
REF52 cells were suspended in the presence of PP2 (50 
 
 
 
M) or DMSO for
90 min and allowed to adhere to 10 
 
 
 
g/ml FN in the continued presence
of PP2 for the indicated times. Endogenous PAK1 or matched antibody-
specific GAL4 control immunoprecipitates were formed. Kinase reactions
were initiated by adding a mix containing 1 
 
 
 
g of recombinant, kinase-
defective MEK1 (MEK1 K97A; a gift from T. Vomastek (University of Vir-
ginia, Charlottesville, VA), 100 
 
 
 
M ATP, 10 mM MgCl
 
2
 
, 1 mM DTT, and
25 mM Hepes-NaOH, pH 7.4, for 20 min at 30
 
 
 
C. Reactions were termi-
nated with SDS-PAGE sample buffer and resolved on 10% gels. C-Raf ki-
nase assays were performed as described previously (Slack et al., 1999).
 
Immunofluorescence
 
REF52 cells were suspended in serum-free DME for 1 h at 37
 
 
 
C and plated
on coverslips coated with 10 
 
 
 
g/ml FN for 10 min or 1 h. The cells were
rinsed three times with PBS before fixing and staining. P-MAPK staining
was performed as described previously (Zecevic et al., 1998). P-S298
MEK1 staining was performed after fixing the cells with 4% PFA in PBS,
permeabilizing with 0.5% Triton X-100, and blocking in 20% NGS and
2% BSA. Cells were incubated with anti–p-S298 MEK1 and antipaxillin an-
tibodies diluted in 10% NGS; 1% BSA followed by FITC-conjugated goat
anti–mouse IgG, and Texas red–conjugated goat anti–rabbit IgG in 0.5%
BSA at a final concentration of 1.5–2 
 
 
 
g/ml each.
 
Online supplemental material
 
Online supplemental figures are available at http://www.jcb.org/cgi/
content/full/jcb.200212141/DC1. The figure legends associated with each
figure provide descriptions as to how the experiments were performed.
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